Data as of Q4 2025 (Dec 31, 2025)

CARLSMED, INC.

(CARL)

Financial Statements · SEC EDGAR XBRL

Net Income
-$29.6M
-22.2%
EPS
$-2.12
+65.3%
Op. Income
-$30.6M
-26.7%
FCF
-$29.6M
-15.5%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
$12.5M
$7.1M
$38.0M
$20.0M
$17.0M
$14.3M
$68.6M
$44.2M
-$30.6M
-$24.1M
$1.4M
$1.3M
$940K
-$135K
$0
$0
-$29.6M
-$24.3M
$-2.12
$-6.11
$-2.12
$-6.11
14.2M
4.1M